| pubmed-article:9086160 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C0001849 | lld:lifeskim |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C0035668 | lld:lifeskim |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:9086160 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:9086160 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:9086160 | pubmed:dateCreated | 1997-4-17 | lld:pubmed |
| pubmed-article:9086160 | pubmed:abstractText | The relationship between the presence and severity of AIDS dementia complex (ADC) and the levels of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid (CSF) were assessed. Nineteen patients with ADC (stages 1-3), 6 without ADC (group 1), and 10 (group 2) without ADC but with cryptococcal meningitis or progressive multifocal leukoencephalopathy were studied. There was a significant relationship between increasing CSF virus burden and ADC severity (P = .0006) but not with plasma burden and ADC severity. In group 2, CSF HIV-1 RNA levels in patients with cryptococcal meningitis were elevated. These results show that CSF HIV-1 RNA concentrations correlate well with ADC severity but may also be increased by central nervous system infections, such as cryptococcal meningitis. | lld:pubmed |
| pubmed-article:9086160 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9086160 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086160 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9086160 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9086160 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9086160 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9086160 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:9086160 | pubmed:author | pubmed-author:CunninghamPP | lld:pubmed |
| pubmed-article:9086160 | pubmed:author | pubmed-author:PembertonLL | lld:pubmed |
| pubmed-article:9086160 | pubmed:author | pubmed-author:IffH WHW | lld:pubmed |
| pubmed-article:9086160 | pubmed:author | pubmed-author:BrewB JBJ | lld:pubmed |
| pubmed-article:9086160 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9086160 | pubmed:volume | 175 | lld:pubmed |
| pubmed-article:9086160 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9086160 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9086160 | pubmed:pagination | 963-6 | lld:pubmed |
| pubmed-article:9086160 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9086160 | pubmed:meshHeading | pubmed-meshheading:9086160-... | lld:pubmed |
| pubmed-article:9086160 | pubmed:meshHeading | pubmed-meshheading:9086160-... | lld:pubmed |
| pubmed-article:9086160 | pubmed:meshHeading | pubmed-meshheading:9086160-... | lld:pubmed |
| pubmed-article:9086160 | pubmed:meshHeading | pubmed-meshheading:9086160-... | lld:pubmed |
| pubmed-article:9086160 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9086160 | pubmed:articleTitle | Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. | lld:pubmed |
| pubmed-article:9086160 | pubmed:affiliation | Department of HIV Medicine, St. Vincent's Hospital, Sydney, Australia. | lld:pubmed |
| pubmed-article:9086160 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9086160 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9086160 | lld:pubmed |
